These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7528179)

  • 1. Quantitative-comparative histology of prostatic adenomas in medically and surgically treated patients.
    Dutkiewicz S; Kałczak M
    Int Urol Nephrol; 1994; 26(4):455-60. PubMed ID: 7528179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
    Urologiia; 2004; (5):70-2. PubMed ID: 15560171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia].
    Sakai S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):695-701. PubMed ID: 8709447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia.
    Dutkiewicz S
    Int Urol Nephrol; 1996; 28(1):49-53. PubMed ID: 8738619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
    Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
    Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and retrospective evaluation of Eviprostat: a non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Tomaru M; Nakada T; Mitobe K
    Int Urol Nephrol; 1995; 27(1):61-6. PubMed ID: 7542229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy.
    Moody JA; Lingeman JE
    J Urol; 2001 Feb; 165(2):459-62. PubMed ID: 11176396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic histology in secondary transurethral resection of the prostate.
    Jønler M; Bruskewitz RC
    J Urol; 1995 Jul; 154(1):119-22. PubMed ID: 7539855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
    Morita T
    J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
    Shapiro E; Becich MJ; Hartanto V; Lepor H
    J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is a single prostatic biopsy sufficient for selection of medical treatment in benign prostatic hypertrophy?].
    Zlotta AR; Sattar AA; Wespes E; Haot J; Schulman CC
    Acta Urol Belg; 1995 Mar; 63(1):83-7. PubMed ID: 7537013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
    Adriazola Semino M; Lozano Ortega JL; García Cobo E; Tejeda Báñez E; Romero Rodríguez F
    Arch Esp Urol; 1992 Apr; 45(3):211-3. PubMed ID: 1384438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
    Robert M; Costa P; Bressolle F; Mottet N; Navratil H
    Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen.
    Song L; Zhu Y; Han P; Chen N; Lin D; Lai J; Wei Q
    Urology; 2011 Mar; 77(3):688-92. PubMed ID: 20974483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary culture of smooth muscle cells from benign prostatic hyperplasia.
    Wu YX; Kawabe K
    J Smooth Muscle Res; 1994 Apr; 30(2):51-6. PubMed ID: 7519907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: correlation of resected weight, blood loss and duration of operation.
    Aus G; Bergdahl S; Hugosson J; Norlén L
    Br J Urol; 1994 Jun; 73(6):659-63. PubMed ID: 7518318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical stromal smooth muscle hyperplasia of prostate.
    Leong SS; Vogt PJ; Yu GS
    Urology; 1988 Feb; 31(2):163-7. PubMed ID: 2448943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
    Cadeddu JA; Pearson JD; Lee BR; Landis P; Partin AW; Epstein JI; Carter HB
    Urology; 1995 May; 45(5):795-800. PubMed ID: 7538241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.